2025 Japan Allergy Diagnostics Market Revenue Opportunities Report
Description
The 2025 Japan Allergy Diagnostics Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Allergy Diagnostics Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Japan allergy diagnostics market are Danaher Corporation, Thermo Fisher Scientific Inc., Siemens Healthineers AG, and Canon, Inc. (through its subsidiary Minaris Medical America, Inc.). Danaher leads globally by market share, operating in allergy diagnostics via its Beckman Coulter subsidiary, which supplies advanced diagnostic tools for allergy testing used in hospitals and clinics. Thermo Fisher Scientific holds the second position, leveraging its broad product portfolio, notably the Phadia allergy testing equipment, with extensive regional presence. Siemens Healthineers brings German precision diagnostics to the market, focusing on in vitro testing and molecular allergy diagnostics. Canon, via Minaris Medical, provides innovative in vitro multiplex allergy tests like the OPTIGEN IgE assay, distributing technology in over 20 countries including Japan.
In Japan specifically, the allergy diagnostics market is growing due to increased environmental pollution, lifestyle changes, and technological advances enhancing test accuracy. These four companies contribute through continuous innovation in molecular and multiplex testing and strategic expansion. For example, Danaher's Beckman Coulter launched a next-generation Basophil Activation Test improving food allergy diagnosis safety and efficiency. Thermo Fisher’s Phadia remains widely used in local clinical labs. Minaris Medical pushes cutting-edge in vitro assays suited to Japan’s demand for sophisticated diagnostics. Overall, their combined investments and advanced diagnostic platforms support Japan’s rising allergy burden and preference for precise, high-quality allergy testing solutions.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Allergy Diagnostics Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Japan allergy diagnostics market are Danaher Corporation, Thermo Fisher Scientific Inc., Siemens Healthineers AG, and Canon, Inc. (through its subsidiary Minaris Medical America, Inc.). Danaher leads globally by market share, operating in allergy diagnostics via its Beckman Coulter subsidiary, which supplies advanced diagnostic tools for allergy testing used in hospitals and clinics. Thermo Fisher Scientific holds the second position, leveraging its broad product portfolio, notably the Phadia allergy testing equipment, with extensive regional presence. Siemens Healthineers brings German precision diagnostics to the market, focusing on in vitro testing and molecular allergy diagnostics. Canon, via Minaris Medical, provides innovative in vitro multiplex allergy tests like the OPTIGEN IgE assay, distributing technology in over 20 countries including Japan.
In Japan specifically, the allergy diagnostics market is growing due to increased environmental pollution, lifestyle changes, and technological advances enhancing test accuracy. These four companies contribute through continuous innovation in molecular and multiplex testing and strategic expansion. For example, Danaher's Beckman Coulter launched a next-generation Basophil Activation Test improving food allergy diagnosis safety and efficiency. Thermo Fisher’s Phadia remains widely used in local clinical labs. Minaris Medical pushes cutting-edge in vitro assays suited to Japan’s demand for sophisticated diagnostics. Overall, their combined investments and advanced diagnostic platforms support Japan’s rising allergy burden and preference for precise, high-quality allergy testing solutions.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
